The Archon Genomics XPrize competition has been cancelled, according to an account from Peter Diamandis, the CEO and chairman of the XPrize Foundation, at the Huffington Post. A spokesperson confirmed to the Daily Scan that the competition is cancelled.

Diamandis writes that the "competition was not incentivizing the technological changes that our prize chair, Dr. Craig Venter, our sponsors Stewart and Marilyn Blusson, and the XPrize board had intended."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.